期刊文献+

系统性红斑狼疮并发肺动脉高压的危险因素分析 被引量:1

下载PDF
导出
摘要 目的探讨系统性红斑狼疮(SLE)并发肺动脉高压(PH)的危险因素。方法回顾性分析72例SLE患者,按是否并发肺动脉高压分组,对症状、体征及血清学指标进行分析。结果本组SLE患者中共有7例并发PH,但并发PH的SLE患者没有心肺相关症状。SLE并发PH的患者SLE疾病活动性指数(SLEDAI)评分显著高于无PH组(P<0.01)。SLE并发PH患者血尿酸水平明显高于无PH的SLE患者(P<0.01)。Logistic回归分析显示,血尿酸是SLE患者发生PH的独立影响因素。结论 SLE并发PH的患者往往由于症状不明显而延误诊断。血尿酸水平或许可作为预测SLE并发PH的重要标记物。
出处 《浙江实用医学》 2015年第1期18-20,共3页 Zhejiang Practical Medicine
基金 金华科技局基金资助项目(20093018)
  • 相关文献

参考文献10

  • 1Ruiz-Irastorza G,Garmendia M ,Villar I,et ahPulmonary hyper- tension in systemic lupus erythematosus: prevalence, predic- tors and diagnostic strategy.Autoimmun Rev,2013,12(3):410.
  • 2Nobre C,Mesquita D,Thomas B,et al.Echocardiography in pulmonary hypertension.Chest, 2013,144 (4) : 1426.
  • 3滕佳临,张巍.系统性红斑狼疮合并肺动脉高压患者临床特点分析[J].中华医学杂志,2014,94(13):969-972. 被引量:14
  • 4邹霓,白秀芝,谢冰.系统性红斑狼疮继发肺动脉高压临床对比分析[J].中国实用医刊,2013,40(5):69-71. 被引量:1
  • 5Gali N,Palazzini M,Manes A.Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed.Eur Respir J,2010,36(5) :986.
  • 6Lau E M,Manes A,Celermajer D S,et al.Early detection of pulmonary vascular disease in pulmonary arterial hyperten- sion: time to move forward.Eur Heart J,2011,32(20) :2489.
  • 7Cefle A,Inanc M,Sayarlioglu M,et al.Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphos- pholipid antibodies and severe disease outcome.Rheumatol Int,2011,31 (2) :83.
  • 8Lau E M,Manes A,Celermajer D 5,et al.Early detection o1 pulmonary vascular disease in pulmonary arterial hyperten- sion: time to move forward.Eur Heart J,2011,32(20) :2489.
  • 9Shah D,Kiran R,Wanehu A,et al.Oxidative stress in sys- temic lupus erythematosus: relationship to Thl cytokine and disease activity. Immunol Lett ,2010,129( 1 ) :7.
  • 10Lin JL,Thomas PS.Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary dis- ease.COPD ,2010,7 (4) :291.

二级参考文献23

  • 1李海云,郑毅.结缔组织病合并间质性肺疾病的研究进展[J].中华风湿病学杂志,2005,9(7):438-441. 被引量:28
  • 2Hassoun PM. Pulmonary arterial hypertension complicating connective tissue diseases [ J ]. Semin Respir Crit Care Med, 2009, 30:429-439.
  • 3Amaud L, Agard C, Haroche J, et al. Pulmonary arterial hypertension in systemic lupus erythematosus [ J ]. Rev Med Interne, 2011, 32:689-697.
  • 4Ruiz-Irastorza G, Garmendia M, Villar I, et al. Pulmonary hypertension in systemic lupus erythematosus : prevalence, predictors and diagnostic strategy[ J]. Autoimmun Rev, 2013 , 12:410-415.
  • 5Kasparian A, Floros A, Gialafos E,et al. Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus[ J]. Lupus,2007,16: 505-508.
  • 6Lian F, Chen D, Wang Y, et al. Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus [ J ]. Rheumatol Int, 2012, 32: 1727-1731.
  • 7Chow SL, Chandran V, Fazelzad R, et al. Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension[ J]. Lupus, 2012 ,21:353-364.
  • 8Chung SM, Lee CK, Lee EY, et al. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension [ J ]. Clin Rheumatol, 2006,25 : 866-872.
  • 9Dhala A. Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction [ J ]. Clin Dev Immunol, 2012,2012:854941.
  • 10Jais X, Launay D, Yaici A, et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension : a retrospective analysis of twenty-three cases[J]. Arthritis Rheum, 2008 ,58:521-531.

共引文献13

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部